
Therapeutic antibodies have become one of the most important classes of biopharmaceuticals, demonstrating remarkable success in oncology, autoimmune diseases, infectious diseases, metabolic disorders, and rare diseases. The growing demand for highly specific and effective antibody therapeutics has accelerated the need for advanced antibody discovery technologies capable of identifying high-quality lead candidates with improved affinity, specificity, and developability. Our antibody discovery services platform provides comprehensive, end-to-end solutions that support antibody generation, screening, characterization, optimization, and early-stage evaluation. By integrating multiple cutting-edge discovery technologies, including hybridoma technology, single-domain antibody discovery, single B-cell screening, anti-drug antibody preparation, antibody functional evaluation, and antibody engineering technologies, we help clients efficiently advance antibody candidates from target identification to preclinical development. Supported by experienced scientists, advanced screening platforms, and robust analytical capabilities, we deliver customized antibody discovery strategies tailored to diverse targets and therapeutic modalities, accelerating the development of next-generation biologics.
Service Overview
Our integrated antibody discovery platform encompasses the complete antibody development workflow, from antigen design and immunization to antibody screening, sequence identification, functional characterization, and optimization. Our services are designed to support the discovery of:
- Hybridoma antibodies
- Single-domain antibodies (VHH antibodies)
- Mono-B cell antibodies
- Anti-drug antibodies
- Monoclonal antibodies (mAbs)
- Fully human antibodies
- Humanized antibodies
- Bispecific antibodies
- Therapeutic antibody candidates
- Diagnostic antibodies
- Research-grade antibodies
Applications
Our antibody discovery services support projects across a broad range of therapeutic areas, including:
- Oncology
- Immunology and inflammation
- Autoimmune diseases
- Infectious diseases
- Neurological disorders
- Metabolic diseases
- Rare diseases
- Cardiovascular disorders
In addition to therapeutic development, our services are widely used for diagnostic assay development, biomarker discovery, target validation, and basic research applications.
Why Choose Us
- Comprehensive technology portfolio: We integrate multiple antibody discovery platforms, enabling the selection of the most suitable approach for each target and project.
- End-to-end support: From antigen design and antibody generation to characterization, optimization, and preclinical support, we provide seamless project management throughout the development process.
- Scientific expertise: Our multidisciplinary team possesses extensive experience in immunology, molecular biology, protein engineering, antibody pharmacology, and biologics development.
- Customized solutions: Every project is designed according to target characteristics, therapeutic objectives, and development timelines, ensuring maximum efficiency and success.
- Fast turnaround and high success rates: Advanced screening technologies, automated workflows, and robust evaluation platforms enable rapid identification of high-quality antibody candidates.
- High-quality data and regulatory readiness: Robust analytical characterization and comprehensive documentation support smooth transition into preclinical development and regulatory submissions.
Overall Solutions
| Project Name | Antibody Discovery Services |
| Service Options | |
| Deliverables | Original images and raw data. A complete experimental report, including experimental materials, experimental procedures, and experimental results. |
| Cycle | Decide according to your needs. |
Whether you are developing hybridoma antibodies, single-domain antibodies, mono-B cell antibodies, anti-drug antibodies, or other novel biologics, our integrated Antibody Discovery Services platform provides the expertise, technologies, and scientific support needed to accelerate your program from concept to candidate selection. We are committed to delivering high-quality antibody solutions that help transform innovative ideas into successful therapeutic products.
Contact Us
Related Services
It should be noted that our service is only used for research, not for clinical use.